Wilmer Cutler Pickering Hale and Dorr represented Medtronic, Inc. in the offering. Medtronic plc (NYSE: MDT) announced it closed its €3 billion public offering, consisting of...
Medtronic’s €3.0 Billion Senior Notes Offering
MKS Instruments’ $1.4 Billion Convertible Senior Notes Offering
Wilmer Cutler Pickering Hale and Dorr advised MKS Instruments, Inc. on the offering, and Davis Polk & Wardwell advised the representatives of the initial purchasers. MKS...
Solid Biosciences’ $109 Million Private Placement
Wilmer Cutler Pickering Hale and Dorr advised Solid Biosciences Inc. on the deal. Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic medicines...
Voyager Therapeutics’ $100 Million Common Stock Offering
Wilmer Cutler Pickering Hale and Dorr advised Voyager Therapeutics, Inc. on the offering, and Cooley advised the underwriters. Voyager Therapeutics, Inc. (Nasdaq: VYGR) announced an underwritten public offering...
Voyager Therapeutics’ Capsid License Agreement and Strategic Collaboration with Novartis
Wilmer Cutler Pickering Hale and Dorr represented Voyager Therapeutics, Inc. in the transaction. Voyager Therapeutics, Inc. (Nasdaq: VYGR) announced a strategic collaboration and capsid license agreement with...
WEX’s $250 Million Acquisition of Payzer
Wilmer Cutler Pickering Hale and Dorr is representing WEX in the transaction. WEX (NYSE: WEX) announced the signing of a definitive agreement to acquire Payzer. Pursuant to...
Akamai Technologies’ $1.1 Billion Convertible Senior Notes Offering
Wilmer Cutler Pickering Hale and Dorr represented Akamai Technologies, Inc., and Davis Polk & Wardwell advised the representatives of the initial purchasers in the offering. Akamai...
Voyager Therapeutics’ Collaboration Agreement with Neurocrine Biosciences
Wilmer Cutler Pickering Hale and Dorr advised Voyager Therapeutics on the deal. Voyager Therapeutics announced that it entered into a strategic collaboration agreement with Neurocrine Biosciences...
P10’s $240 Million Initial Public Offering
Olshan Frome Wolosky represented P10 in the transaction, while Davis Polk advised the representatives of the several underwriters. P10, Inc., a leading private markets solutions provider, announced...